Pulmonary Diseases Completed Phase 2 / 3 Trials for Nitric Oxide (DB00435)

Also known as: Disease, Pulmonary / Pulmonary Disease

IndicationStatusPhase
DBCOND0033751 (Pulmonary Diseases)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01503801Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary DysplasiaTreatment